Home › diabetes
 

Keywords :   


Tag: diabetes

Diabetes Disaster Preparedness

2014-02-21 16:03:06| PortlandOnline

Checklist and tips from the Center for Infectious Disease Research and Policy.

Tags: disaster diabetes preparedness disaster preparedness

 

Merck and Samsung Bioepis Enter Collaboration Agreement to Develop and Commercialize Insulin Glargine Candidate for Diabetes

2014-02-10 14:43:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. & SEOUL, SOUTH KOREA WHITEHOUSE STATION, N.J. & SEOUL, SOUTH KOREA--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon. Language: English Contact: Merck Media InquiriesKim Hamilton, 908-423-6831orCaroline Lappetito, 267-305-7639orMerck Investor RelationsCarol Ferguson, 908-423-4465orSamsung Media InquiriesHongSeok Ji, +82-32-455-6102orSamsung Investor RelationsSungjoon Park, +82-32-455-6120 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: for enter agreement develop

 
 

Bristol-Myers completes diabetes business sale

2014-02-03 17:46:40| Biotech - Topix.net

Drug developer Bristol-Myers Squibb Co. has received a $2.7 billion payment from Anglo-Swedish counterpart AstraZeneca PLC as part of the sale of its global diabetes business, a deal that could eventually be worth more than $4 billion.

Tags: business sale diabetes completes

 

Sanofi sues Eli Lilly over challenge to top diabetes drug Lantus

2014-01-31 18:18:55| Biotech - Topix.net

French drugmaker Sanofi is suing Eli Lilly and Co for alleged patent infringements concerning its top-selling Lantus diabetes treatment, delaying the U.S. firm's plans to produce a copycat version of Lantus.

Tags: top drug challenge diabetes

 

GSK's diabetes drug set for European approval

2014-01-24 17:55:29| Biotech - Topix.net

GlaxoSmithKline said on Friday European regulators had given the green light to its once-weekly diabetes drug albiglutide, which it is marketing as Eperzan.

Tags: set drug european approval

 

Sites : [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] next »